Stay updated on Azacitidine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine + Pembrolizumab in AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer revision label was updated from v3.8.0 to v3.8.1, with the clinical trial record unchanged.
    Difference
    0.1%
    Check dated 2026-11-18T02:36:45.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The record now provides details of the completed phase 2 azacitidine–pembrolizumab study, including its cohorts, eligibility criteria, locations, outcomes, and study documents.
    Difference
    59%
    Check dated 2026-11-11T01:39:03.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer's site revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-03T23:58:56.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A general NIH notice about using “Super Intelligence” instead of “Artificial Intelligence” appears on the page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:00:05.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The footer revision identifier updates from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:14:27.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with standard site chrome, replacing the usual study record content. This indicates that access to the page is blocked.
    Difference
    20%
    Check dated 2026-09-23T00:29:05.000Z thumbnail image

Stay in the know with updates to Azacitidine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.